APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Heart Lung Machines

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Selected research

Market Structure

Global Artificial Heart Lung Machines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026187 pages

Choose your research edition.

Industry ResearchArtificial Heart Lung Machines Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Heart Lung Machines Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Artificial Heart Lung Machines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Heart Lung Machines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Heart Lung Machines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Global Artificial Heart Lung Machines key players include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%. And in terms of application, the largest application is Cardiac Surgery, followed by Lung Transplant Operation, Acute Respiratory Failure Treatment, etc.

This report provides an overview of the global Artificial Heart Lung Machines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Artificial Heart Lung Machines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Heart Lung Machines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artificial Heart Lung Machines market size, projected growth trends, production technologies, key applications, and end-use industries.

Artificial Heart Lung Machines Segment by Company

LivaNova (Sorin)

Getinge (Maquet)

Medtronic

Terumo CV Group

Braile Biomedica

Tianjin Medical

Artificial Heart Lung Machines Segment by Type

Single Roller Pump HLM

Double Roller Pump HLM

Artificial Heart Lung Machines Segment by Application

Cardiac Surgery

Lung Transplant Operation

Acute Respiratory Failure Treatment

Others

Artificial Heart Lung Machines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Heart Lung Machines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Heart Lung Machines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Heart Lung Machines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artificial Heart Lung Machines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artificial Heart Lung Machines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Artificial Heart Lung Machines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Artificial Heart Lung Machines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Artificial Heart Lung Machines Industry Trends Table 2. Artificial Heart Lung Machines Industry Drivers Table 3. Artificial Heart Lung Machines Industry Opportunities and Challenges Table 4. Artificial Heart Lung Machines Industry Restraints Table 5. Global Artificial Heart Lung Machines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Artificial Heart Lung Machines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Artificial Heart Lung Machines Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Artificial Heart Lung Machines Sales Market Share by Manufacturers Table 9. Global Artificial Heart Lung Machines Average Sales Price (K USD/Unit) of Manufacturers (2021-2026) Table 10. Global Artificial Heart Lung Machines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Artificial Heart Lung Machines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Artificial Heart Lung Machines Manufacturers, Product Type & Application Table 13. Global Artificial Heart Lung Machines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Artificial Heart Lung Machines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single Roller Pump HLM Table 17. Major Manufacturers of Double Roller Pump HLM Table 18. Global Artificial Heart Lung Machines Sales by Type 2021 VS 2025 VS 2032 (Units) Table 19. Global Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units) Table 20. Global Artificial Heart Lung Machines Sales by Type (2027-2032) & (Units) Table 21. Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2026) Table 22. Global Artificial Heart Lung Machines Sales Market Share by Type (2027-2032) Table 23. Global Artificial Heart Lung Machines Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 24. Global Artificial Heart Lung Machines Revenue by Type (2021-2026) & (Units) Table 25. Global Artificial Heart Lung Machines Revenue by Type (2027-2032) & (Units) Table 26. Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2026) Table 27. Global Artificial Heart Lung Machines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cardiac Surgery Table 29. Major Manufacturers of Lung Transplant Operation Table 30. Major Manufacturers of Acute Respiratory Failure Treatment Table 31. Major Manufacturers of Others Table 32. Global Artificial Heart Lung Machines Sales by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Artificial Heart Lung Machines Sales by Application (2021-2026) & (Units) Table 34. Global Artificial Heart Lung Machines Sales by Application (2027-2032) & (Units) Table 35. Global Artificial Heart Lung Machines Sales Market Share by Application (2021-2026) Table 36. Global Artificial Heart Lung Machines Sales Market Share by Application (2027-2032) Table 37. Global Artificial Heart Lung Machines Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 38. Global Artificial Heart Lung Machines Revenue by Application (2021-2026) & (Units) Table 39. Global Artificial Heart Lung Machines Revenue by Application (2027-2032) & (Units) Table 40. Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2026) Table 41. Global Artificial Heart Lung Machines Revenue Market Share by Application (2027-2032) Table 42. Global Artificial Heart Lung Machines Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Artificial Heart Lung Machines Sales by Region (2021-2026) & (Units) Table 44. Global Artificial Heart Lung Machines Sales Market Share by Region (2021-2026) Table 45. Global Artificial Heart Lung Machines Sales Forecasted by Region (2027-2032) & (Units) Table 46. Global Artificial Heart Lung Machines Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Artificial Heart Lung Machines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 48. North America Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units) Table 49. North America Artificial Heart Lung Machines Sales by Country (2027-2032) & (Units) Table 50. Europe Artificial Heart Lung Machines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 51. Europe Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units) Table 52. Europe Artificial Heart Lung Machines Sales by Country (2027-2032) & (Units) Table 53. Asia Pacific Artificial Heart Lung Machines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Asia Pacific Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units) Table 55. Asia Pacific Artificial Heart Lung Machines Sales by Country (2027-2032) & (Units) Table 56. South America, Middle East and Africa Artificial Heart Lung Machines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 57. South America, Middle East and Africa Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units) Table 58. South America, Middle East and Africa Artificial Heart Lung Machines Sales by Country (2027-2032) & (Units) Table 59. Global Artificial Heart Lung Machines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Artificial Heart Lung Machines Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Artificial Heart Lung Machines Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Artificial Heart Lung Machines Revenue Market Share by Region (2021-2026) Table 63. Global Artificial Heart Lung Machines Revenue Market Share by Region (2027-2032) Table 64. LivaNova (Sorin) Company Information Table 65. LivaNova (Sorin) Business Overview Table 66. LivaNova (Sorin) Artificial Heart Lung Machines Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio Table 68. LivaNova (Sorin) Recent Development Table 69. Getinge (Maquet) Company Information Table 70. Getinge (Maquet) Business Overview Table 71. Getinge (Maquet) Artificial Heart Lung Machines Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio Table 73. Getinge (Maquet) Recent Development Table 74. Medtronic Company Information Table 75. Medtronic Business Overview Table 76. Medtronic Artificial Heart Lung Machines Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Medtronic Artificial Heart Lung Machines Product Portfolio Table 78. Medtronic Recent Development Table 79. Terumo CV Group Company Information Table 80. Terumo CV Group Business Overview Table 81. Terumo CV Group Artificial Heart Lung Machines Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Terumo CV Group Artificial Heart Lung Machines Product Portfolio Table 83. Terumo CV Group Recent Development Table 84. Braile Biomedica Company Information Table 85. Braile Biomedica Business Overview Table 86. Braile Biomedica Artificial Heart Lung Machines Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Braile Biomedica Artificial Heart Lung Machines Product Portfolio Table 88. Braile Biomedica Recent Development Table 89. Tianjin Medical Company Information Table 90. Tianjin Medical Business Overview Table 91. Tianjin Medical Artificial Heart Lung Machines Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Tianjin Medical Artificial Heart Lung Machines Product Portfolio Table 93. Tianjin Medical Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Artificial Heart Lung Machines Distributors List Table 97. Artificial Heart Lung Machines Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Artificial Heart Lung Machines Product Image Figure 2. Global Artificial Heart Lung Machines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Heart Lung Machines Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Heart Lung Machines Sales (2021-2032) & (Units) Figure 5. Global Artificial Heart Lung Machines Average Price (K USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Artificial Heart Lung Machines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single Roller Pump HLM Image Figure 9. Double Roller Pump HLM Image Figure 10. Global Artificial Heart Lung Machines Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 11. Global Artificial Heart Lung Machines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2032) Figure 13. Global Artificial Heart Lung Machines Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Artificial Heart Lung Machines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2032) Figure 16. Cardiac Surgery Image Figure 17. Lung Transplant Operation Image Figure 18. Acute Respiratory Failure Treatment Image Figure 19. Others Image Figure 20. Global Artificial Heart Lung Machines Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Artificial Heart Lung Machines Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Artificial Heart Lung Machines Sales Market Share by Application (2021-2032) Figure 23. Global Artificial Heart Lung Machines Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Artificial Heart Lung Machines Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2032) Figure 26. North America Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 27. North America Artificial Heart Lung Machines Sales Market Share by Country (2021-2032) Figure 28. U.S. Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 29. Canada Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 30. Mexico Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 32. Europe Artificial Heart Lung Machines Sales Market Share by Country (2021-2032) Figure 33. Germany Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 34. France Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 35. U.K. Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 36. Italy Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 37. Netherlands Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 39. Asia Pacific Artificial Heart Lung Machines Sales Market Share by Country (2021-2032) Figure 40. China Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 41. Japan Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 42. South Korea Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 43. Southeast Asia Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 44. India Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 45. Australia Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 47. South America, Middle East and Africa Artificial Heart Lung Machines Sales Market Share by Country (2021-2032) Figure 48. Brazil Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 49. South Africa Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 50. Saudi Arabia Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 51. Turkey Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 52. Argentina Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 53. UAE Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 54. Egypt Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 55. Chile Artificial Heart Lung Machines Sales and Growth Rate (2021-2032) & (Units) Figure 56. Global Artificial Heart Lung Machines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Artificial Heart Lung Machines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Artificial Heart Lung Machines Revenue (2021-2032) & (US$ Million) Figure 59. North America Artificial Heart Lung Machines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Artificial Heart Lung Machines Revenue (2021-2032) & (US$ Million) Figure 61. Europe Artificial Heart Lung Machines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Artificial Heart Lung Machines Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Artificial Heart Lung Machines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Artificial Heart Lung Machines Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Artificial Heart Lung Machines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Artificial Heart Lung Machines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Artificial Heart Lung Machines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Single Roller Pump HLM
  • Double Roller Pump HLM
Applications
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Others
Companies covered
  • LivaNova (Sorin)
  • Getinge (Maquet)
  • Medtronic
  • Terumo CV Group
  • Braile Biomedica
  • Tianjin Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artificial Heart Lung Machines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artificial Heart Lung Machines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Artificial Heart Lung Machines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Artificial Heart Lung Machines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Artificial Heart Lung Machines Market Dynamics
  1. 2.1 Artificial Heart Lung Machines Industry Trends
  2. 2.2 Artificial Heart Lung Machines Industry Drivers
  3. 2.3 Artificial Heart Lung Machines Industry Opportunities and Challenges
  4. 2.4 Artificial Heart Lung Machines Industry Restraints
3 Artificial Heart Lung Machines Market by Manufacturers
  1. 3.1 Global Artificial Heart Lung Machines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Artificial Heart Lung Machines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Artificial Heart Lung Machines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Artificial Heart Lung Machines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Artificial Heart Lung Machines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Artificial Heart Lung Machines Manufacturers, Product Type & Application
  7. 3.7 Global Artificial Heart Lung Machines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Artificial Heart Lung Machines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Artificial Heart Lung Machines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Artificial Heart Lung Machines Tier 1, Tier 2, and Tier 3
4 Artificial Heart Lung Machines Market by Type
  1. 4.1 Artificial Heart Lung Machines Type Introduction
  2. 4.1.1 Single Roller Pump HLM
  3. 4.1.2 Double Roller Pump HLM
  4. 4.2 Global Artificial Heart Lung Machines Sales by Type
  5. 4.2.1 Global Artificial Heart Lung Machines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Artificial Heart Lung Machines Sales by Type (2021-2032)
  7. 4.2.3 Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Artificial Heart Lung Machines Revenue by Type
  9. 4.3.1 Global Artificial Heart Lung Machines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Artificial Heart Lung Machines Revenue by Type (2021-2032)
  11. 4.3.3 Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2032)
5 Artificial Heart Lung Machines Market by Application
  1. 5.1 Artificial Heart Lung Machines Application Introduction
  2. 5.1.1 Cardiac Surgery
  3. 5.1.2 Lung Transplant Operation
  4. 5.1.3 Acute Respiratory Failure Treatment
  5. 5.1.4 Others
  6. 5.2 Global Artificial Heart Lung Machines Sales by Application
  7. 5.2.1 Global Artificial Heart Lung Machines Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Artificial Heart Lung Machines Sales by Application (2021-2032)
  9. 5.2.3 Global Artificial Heart Lung Machines Sales Market Share by Application (2021-2032)
  10. 5.3 Global Artificial Heart Lung Machines Revenue by Application
  11. 5.3.1 Global Artificial Heart Lung Machines Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Artificial Heart Lung Machines Revenue by Application (2021-2032)
  13. 5.3.3 Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2032)
6 Global Artificial Heart Lung Machines Sales by Region
  1. 6.1 Global Artificial Heart Lung Machines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Heart Lung Machines Sales by Region (2021-2032)
  3. 6.2.1 Global Artificial Heart Lung Machines Sales by Region (2021-2026)
  4. 6.2.2 Global Artificial Heart Lung Machines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artificial Heart Lung Machines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Artificial Heart Lung Machines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Artificial Heart Lung Machines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Artificial Heart Lung Machines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Artificial Heart Lung Machines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Artificial Heart Lung Machines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Artificial Heart Lung Machines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Artificial Heart Lung Machines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Artificial Heart Lung Machines Revenue by Region
  1. 7.1 Global Artificial Heart Lung Machines Revenue by Region
  2. 7.1.1 Global Artificial Heart Lung Machines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Artificial Heart Lung Machines Revenue by Region (2021-2026)
  4. 7.1.3 Global Artificial Heart Lung Machines Revenue by Region (2027-2032)
  5. 7.1.4 Global Artificial Heart Lung Machines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Artificial Heart Lung Machines Revenue (2021-2032)
  8. 7.2.2 North America Artificial Heart Lung Machines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Artificial Heart Lung Machines Revenue (2021-2032)
  11. 7.3.2 Europe Artificial Heart Lung Machines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Artificial Heart Lung Machines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Artificial Heart Lung Machines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Artificial Heart Lung Machines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Artificial Heart Lung Machines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 LivaNova (Sorin)
  2. 8.1.1 LivaNova (Sorin) Company Information
  3. 8.1.2 LivaNova (Sorin) Business Overview
  4. 8.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio
  6. 8.1.5 LivaNova (Sorin) Recent Developments
  7. 8.2 Getinge (Maquet)
  8. 8.2.1 Getinge (Maquet) Company Information
  9. 8.2.2 Getinge (Maquet) Business Overview
  10. 8.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio
  12. 8.2.5 Getinge (Maquet) Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Artificial Heart Lung Machines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Artificial Heart Lung Machines Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Terumo CV Group
  20. 8.4.1 Terumo CV Group Company Information
  21. 8.4.2 Terumo CV Group Business Overview
  22. 8.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Terumo CV Group Artificial Heart Lung Machines Product Portfolio
  24. 8.4.5 Terumo CV Group Recent Developments
  25. 8.5 Braile Biomedica
  26. 8.5.1 Braile Biomedica Company Information
  27. 8.5.2 Braile Biomedica Business Overview
  28. 8.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Braile Biomedica Artificial Heart Lung Machines Product Portfolio
  30. 8.5.5 Braile Biomedica Recent Developments
  31. 8.6 Tianjin Medical
  32. 8.6.1 Tianjin Medical Company Information
  33. 8.6.2 Tianjin Medical Business Overview
  34. 8.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tianjin Medical Artificial Heart Lung Machines Product Portfolio
  36. 8.6.5 Tianjin Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artificial Heart Lung Machines Value Chain Analysis
  2. 9.1.1 Artificial Heart Lung Machines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artificial Heart Lung Machines Production Mode & Process
  6. 9.2 Artificial Heart Lung Machines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artificial Heart Lung Machines Distributors
  9. 9.2.3 Artificial Heart Lung Machines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst